A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

NCT06949267 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Acute Graft-versus-Host Disease

Interventions

BIOLOGICAL: iMSC
COMBINATION_PRODUCT: conventional aGVHD prophylaxis

Sponsor

Ruijin Hospital